Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.



Jeffrey Albers

CEO, President and Chairman of the Board of Directors

Percy Carter, MBA, Ph.D.

Chief Scientific Officer

Debbie Durso-Bumpus

Senior Vice President, Human Resources

Kate Haviland

Chief Operating Officer

Becker Hewes, M.D.

Chief Medical Officer

Mike Landsittel

Chief Financial Officer

Tracey L. McCain, Esq.

Executive Vice President, Chief Legal and Compliance Officer

Christopher Murray, Ph.D.

Senior Vice President, Technical Operations

Fouad Namouni, M.D.

President, Research & Development

Christina Rossi

Chief Commercial Officer